|
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified
|
3 Months Ended |
138 Months Ended |
|
Mar. 31, 2012
|
Mar. 31, 2011
|
Mar. 31, 2012
|
| Cash flows from operating activities: |
|
|
|
|
|
| Net loss |
$ (872) |
|
$ (705) |
$ (44,950) |
[1] |
| Less - loss for the period from discontinued operations |
0 |
|
0 |
164 |
[1] |
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
| Depreciation and amortization of deferred charges |
38 |
|
38 |
1,039 |
[1] |
| Severance pay, net |
1 |
|
(8) |
13 |
[1] |
| Accrued interest on loans |
0 |
|
0 |
451 |
[1] |
| Amortization of discount on short-term loans |
0 |
|
0 |
1,864 |
[1] |
| Change in fair value of options and warrants |
0 |
|
0 |
(795) |
[1] |
| Expenses related to shares and options granted to service providers |
4 |
|
(20) |
21,490 |
[1] |
| Stock-based compensation related to options granted to employees |
177 |
|
27 |
6,998 |
[1] |
| Decrease (increase) in accounts receivable and prepaid expenses |
(249) |
|
265 |
(630) |
[1] |
| Increase in trade payables and convertible note |
81 |
|
94 |
798 |
[1] |
| Increase in other accounts payable and accrued expenses |
74 |
|
254 |
1,471 |
[1] |
| Erosion of restricted cash |
0 |
|
0 |
(6) |
[1] |
| Net cash used in continuing operating activities |
(746) |
|
(55) |
(12,093) |
[1] |
| Net cash used in discontinued operating activities |
0 |
|
0 |
(23) |
[1] |
| Total net cash used in operating activities |
(746) |
|
(55) |
(12,116) |
[1] |
| Cash flows from investing activities: |
|
|
|
|
|
| Purchase of property and equipment |
(52) |
|
(37) |
(1,185) |
[1] |
| Restricted cash |
0 |
|
0 |
6 |
[1] |
| Investment in lease deposit |
0 |
|
1 |
(17) |
[1] |
| Net cash used in continuing investing activities |
(52) |
|
(36) |
(1,196) |
[1] |
| Net cash used in discontinued investing activities |
0 |
|
0 |
(16) |
[1] |
| Total net cash used in investing activities |
(52) |
|
(36) |
(1,212) |
[1] |
| Cash flows from financing activities: |
|
|
|
|
|
| Proceeds from issuance of Common stock, net |
0 |
|
3,607 |
12,319 |
[1] |
| Proceeds from loans, notes and issuance of warrants, net |
0 |
|
0 |
2,061 |
[1] |
| Proceeds from exercise of warrants and options |
20 |
|
55 |
651 |
[1] |
| Repayment of short-term loans |
0 |
|
0 |
(601) |
[1] |
| Net cash provided by continuing financing activities |
20 |
|
3,662 |
14,430 |
[1] |
| Net cash provided by discontinued financing activities |
0 |
|
0 |
43 |
[1] |
| Total net cash provided by financing activities |
20 |
|
3,662 |
14,473 |
[1] |
| Increase (decrease) in cash and cash equivalents |
(778) |
|
3,571 |
1,145 |
[1] |
| Cash and cash equivalents at the beginning of the period |
1,923 |
|
93 |
0 |
|
| Cash and cash equivalents at end of the period |
1,145 |
[1] |
3,664 |
1,145 |
[1] |
| Non-cash financing activities: |
|
|
|
|
|
| Conversion of convertible loan and convertible note to shares |
|
|
|
|
|
| Conversion of a debt to a trade payable to Common Stock $ 84 |
0 |
|
137 |
|
|
| Conversion of other accounts payable to Common Stock |
$ 0 |
|
$ 24 |
|
|
|
|
|